Pharmabiz1d
Rakuten Medical initiates global phase 3 trial of ASP-1929 photoimmunotherapy in combo with pembrolizumab to treat recurrent head and neck cancer
Rakuten Medical initiates global phase 3 trial of ASP-1929 photoimmunotherapy in combo with pembrolizumab to treat recurrent head and neck cancer: United States Saturday, January ...
Pharmabiz1d
Körber appoints Oliver Weber as CEO software in the Business Area Pharma
Körber appoints Oliver Weber as CEO software in the Business Area Pharma: Lüneburg, Germany Saturday, January 25, 2025, 17:00 ...
Pharmabiz1d
Zerion Pharma & Aché collaborate to exploit the Dispersome technology for improvement of two marketed drug products
Zerion Pharma & Aché collaborate to exploit the Dispersome technology for improvement of two marketed drug products: Copenhagen, Denmark Saturday, January 25, 2025, 16:00 Hrs [IS ...
Pharmabiz1d
Larimar doses adolescents in nomlabofusp paediatric pharmacokinetic run-in study for patients with Friedreich’s ataxia
Larimar doses adolescents in nomlabofusp paediatric pharmacokinetic run-in study for patients with Friedreich’s ataxia: Bala Cynwyd, Pennsylvania Saturday, January 25, 2025, 15: ...
Pharmabiz1d
NPPA seeks market-based price data on four IVs for ceiling price fixation
The National Pharmaceutical Pricing Authority (NPPA) has asked the manufacturers and marketers to submit price data on four intravenous (IV) fluids at certain strengths, in order to fix the ceiling ...
Pharmabiz1d
Tiziana Life Sciences announces positive results from studies using nasal anti-CD3 mAb in traumatic spinal cord injury
Tiziana Life Sciences announces positive results from studies using nasal anti-CD3 mAb in traumatic spinal cord injury: New York Saturday, January 25, 2025, 13:00 Hrs [IST] Tizian ...
Pharmabiz1d
OGT introduces new NGS SureSeq Myeloid MRD Panel to detect ultra-low frequency MRD-associated biomarkers in AML
OGT introduces new NGS SureSeq Myeloid MRD Panel to detect ultra-low frequency MRD-associated biomarkers in AML: New York, ...
Pharmabiz1d
Attovia Therapeutics doses first participant in phase 1 study of ATTO-1310, its novel HLF anti-IL-31 ATTOBODY to treat chronic pruritus
Attovia Therapeutics doses first participant in phase 1 study of ATTO-1310, its novel HLF anti-IL-31 ATTOBODY to treat chronic pruritus: Fremont, California Saturday, January 25, ...
Pharmabiz1d
BD & Biosero collaborate to enable robotic integration with flow cytometers used in drug discovery and development
Franklin Lakes, New Jersey Saturday, January 25, 2025, 10:00 Hrs [IST] ...
Pharmabiz1d
AstraZeneca plans C$820 million investment in Canada to advance growing global hub and clinical delivery
AstraZeneca plans C$820 million investment in Canada to advance growing global hub and clinical delivery: Mississauga, Ontario Saturday, January 25, 2025, 09:00 Hrs [IST] AstraZen ...
Pharmabiz1d
Demand for medical gloves has seen steep rise with increasing awareness of hygiene & safety: Anindith Reddy
Demand for medical gloves has seen steep rise with increasing awareness of hygiene & safety: Anindith Reddy: Nandita Vijayasimha, Bengaluru Saturday, January 25, 2025, 08:00 Hrs [ ...
Pharmabiz1d
Dentists see dentistry heading towards holistic approach, integrating comprehensive healthcare
Dentists see dentistry heading towards holistic approach, integrating comprehensive healthcare: Nandita Vijayasimha, Bengaluru Saturday, January 25, 2025, 08:00 Hrs [IST] Dentists ...